{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:37Z","timestamp":1761578617451},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11239-017-1524-y","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T03:30:04Z","timestamp":1499657404000},"page":"223-233","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Central aortic pulse pressure, thrombogenicity and cardiovascular risk"],"prefix":"10.1007","volume":"44","author":[{"given":"Gailing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Bliden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himabindu","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliano P.","family":"Navarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","volume":"46","author":"PA Gurbel","year":"2005","unstructured":"Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol 46:1820\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"1524_CR2","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/eurheartj\/ehp330","volume":"30","author":"E Gkaliagkousi","year":"2009","unstructured":"Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, Zamboulis C, Ritter J, Ferro A (2009) Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J 30:3048\u20133054","journal-title":"Eur Heart J"},{"key":"1524_CR3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/07420528.2013.790045","volume":"30","author":"D Erdogan","year":"2013","unstructured":"Erdogan D, Icli A, Aksoy F, Akcay S, Ozaydin M, Ersoy I, Varol E, Dogan A (2013) Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure. Chronobiol Int 30:973\u2013980","journal-title":"Chronobiol Int"},{"key":"1524_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/CH-2010-1327","volume":"45","author":"E Varol","year":"2010","unstructured":"Varol E, Akcay S, Icli A, Yucel H, Ozkan E, Erdogan D, Ozaydin M (2010) Mean platelet volume in patients with prehypertension and hypertension. Clin Hemorheol Microcirc 45:67\u201372","journal-title":"Clin Hemorheol Microcirc"},{"key":"1524_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ajh.2009.247","volume":"23","author":"E Gkaliagkousi","year":"2010","unstructured":"Gkaliagkousi E, Passacquale G, Douma S, Zamboulis C, Ferro A (2010) Platelet activation in essential hypertension: implications for antiplatelet treatment. Am J Hypertens 23:229\u2013236","journal-title":"Am J Hypertens"},{"key":"1524_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.109.853085","volume":"121","author":"PA Gurbel","year":"2010","unstructured":"Gurbel PA, Tantry US (2010) Combination antithrombotic therapies. Circulation 121:569\u2013583","journal-title":"Circulation"},{"key":"1524_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/09537100802687666","volume":"20","author":"PA Gurbel","year":"2009","unstructured":"Gurbel PA, Bliden KP, Kreutz RP, Dichiara J, Antonino MJ, Tantry US (2009) The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting. Platelets 20:97\u2013104","journal-title":"Platelets"},{"key":"1524_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1160\/TH13-08-0643","volume":"111","author":"YH Jeong","year":"2014","unstructured":"Jeong YH, Bliden KP, Shuldiner AR, Tantry US, Gurbel PA (2014) Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes. Thromb Haemost 111:713\u2013724","journal-title":"Thromb Haemost"},{"key":"1524_CR9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/HJH.0b013e3283424b4d","volume":"29","author":"CM Huang","year":"2011","unstructured":"Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH (2011) Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 29:454\u2013459","journal-title":"J Hypertens"},{"key":"1524_CR10","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehq024","volume":"31","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, O\u2019Rourke MF, Safar ME, Baou K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 31:1865\u20131871","journal-title":"Eur Heart J"},{"key":"1524_CR11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","volume":"100","author":"SS Franklin","year":"1999","unstructured":"Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100:354\u2013360","journal-title":"Circulation"},{"key":"1524_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0895-7061(02)02961-8","volume":"15","author":"F Philippe","year":"2002","unstructured":"Philippe F, Chemaly E, Blacher J, Mourad JJ, Dibie A, Larrazet F, Laborde F, Safar ME (2002) Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates. Am J Hypertens 15:672\u2013677","journal-title":"Am J Hypertens"},{"key":"1524_CR13","doi-asserted-by":"crossref","first-page":"e3218","DOI":"10.1097\/MD.0000000000003218","volume":"95","author":"MJ Lin","year":"2016","unstructured":"Lin MJ, Chen CY, Lin HD, Lin CS, Wu HP (2016) Prognostic significance of central pulse pressure for mortality in patients with coronary artery disease receiving repeated percutaneous coronary intervention. Medicine 95:e3218.","journal-title":"Medicine"},{"key":"1524_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"E Mahla","year":"2012","unstructured":"Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, Cho P, Sell J, Fan J, Antonino MJ, Tantry US, Gurbel PA (2012) Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 5:261\u2013269","journal-title":"Circ Cardiovasc Interv"},{"key":"1524_CR15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC\/ACCF\/AHA\/WHF Task Force for the Universal Definition of Myocardial Infarction (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581\u20131598","journal-title":"J Am Coll Cardiol"},{"key":"1524_CR16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","volume":"160","author":"PA Gurbel","year":"2010","unstructured":"Gurbel PA, Bliden KP, Navickas IA, Mahla E, Dichiara J, Suarez TA et al (2010) Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. Am Heart J 160:346\u2013354","journal-title":"Am Heart J"},{"key":"1524_CR17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/09537100903548903","volume":"21","author":"US Tantry","year":"2010","unstructured":"Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA (2010) Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic Risk Progression (TRIP) study. Platelets 21:360\u2013367","journal-title":"Platelets"},{"key":"1524_CR18","doi-asserted-by":"crossref","first-page":"e001167","DOI":"10.1161\/JAHA.114.001167","volume":"3","author":"EI Lev","year":"2014","unstructured":"Lev EI, Bliden KP, Jeong YH, Pandya S, Kang K, Franzese C et al (2014) Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patients. J Am Heart Assoc 3:e001167","journal-title":"J Am Heart Assoc"},{"key":"1524_CR19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ajh\/hpt007","volume":"26","author":"G Ozkan","year":"2013","unstructured":"Ozkan G, Ulusoy S, Mentese A, Karahan SC, Cansiz M (2013) New marker of platelet activation, SCUBE1, is elevated in hypertensive patients. Am J Hypertens 26:748\u2013753","journal-title":"Am J Hypertens"},{"key":"1524_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcmd.2008.07.003","volume":"42","author":"M El Haouari","year":"2009","unstructured":"El Haouari M, Rosado JA (2009) Platelet function in hypertension. Blood Cells Mol Dis 42:38\u201343","journal-title":"Blood Cells Mol Dis"},{"key":"1524_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/09537100500163572","volume":"16","author":"E Coban","year":"2005","unstructured":"Coban E, Yazicioglu G, Berkant Avci A, Akcit F (2005) The mean platelet volume in patients with essential and white coat hypertension. Platelets 16:435\u2013438","journal-title":"Platelets"},{"key":"1524_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2004.03.067","volume":"44","author":"SK Nadar","year":"2004","unstructured":"Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY (2004) Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44:415\u2013422","journal-title":"J Am Coll Cardiol"},{"key":"1524_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08037050903516284","volume":"19","author":"T Inanc","year":"2010","unstructured":"Inanc T, Kaya MG, Yarlioglues M, Ardic I, Ozdogru I, Dogan A et al (2010) The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives. Blood Press 19:81\u201385","journal-title":"Blood Press"},{"key":"1524_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/08037051.2010.532317","volume":"20","author":"M Yarlioglues","year":"2011","unstructured":"Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara HA, Gunturk E et al (2011) Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 20:92\u201397","journal-title":"Blood Press"},{"key":"1524_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.jhh.1000556","volume":"11","author":"AJ Lee","year":"1997","unstructured":"Lee AJ (1997) The role of rheological and haemostatic factors in hypertension. J Hum Hypertens 11:767\u2013776","journal-title":"J Hum Hypertens"},{"key":"1524_CR26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/jhh.2008.170","volume":"23","author":"M Khaleghi","year":"2009","unstructured":"Khaleghi M, Singletary LA, Kondragunta V, Bailey KR, Turner ST, Mosley TH Jr et al (2009) Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens 23:530\u2013537","journal-title":"J Hum Hypertens"},{"key":"1524_CR27","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1002\/clc.20719","volume":"33","author":"P Yang","year":"2010","unstructured":"Yang P, Liu YF, Yang L, Wei Q, Zeng H (2010) Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension. Clin Cardiol 33:E81\u2013E86","journal-title":"Clin Cardiol"},{"key":"1524_CR28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.atherosclerosis.2004.04.021","volume":"176","author":"P Jankowski","year":"2004","unstructured":"Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Brzozowska-Kiszka M, Styczkiewicz K, Styczkiewicz M et al (2004) Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis 176:151\u2013155","journal-title":"Atherosclerosis"},{"key":"1524_CR29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0895-7061(00)01288-7","volume":"14","author":"T Nishijima","year":"2001","unstructured":"Nishijima T, Nakayama Y, Tsumura K, Yamashita N, Yoshimaru K, Ueda H et al (2001) Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens 14:469\u2013473","journal-title":"Am J Hypertens"},{"key":"1524_CR30","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2009.05.070","volume":"54","author":"MJ Roman","year":"2009","unstructured":"Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W et al (2009) High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 54:1730\u20131734","journal-title":"J Am Coll Cardiol"},{"key":"1524_CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.107.089078","volume":"50","author":"MJ Roman","year":"2007","unstructured":"Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T et al (2007) Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 50:197\u2013203","journal-title":"Hypertension"},{"key":"1524_CR32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/hy0202.098325","volume":"39","author":"ME Safar","year":"2002","unstructured":"Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc\u2019h PM et al (2002) Central pulse pressure and mortality in end-stage renal disease. Hypertension 39:735\u2013738","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"1524_CR33","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(16)30357-7","volume":"141","author":"SL Diamond","year":"2016","unstructured":"Diamond SL (2016) Flow and delta-P dictate where thrombin, fibrin, and von Willebrand factor will be found. Thromb Res 141(Suppl 2):S22\u2013S24","journal-title":"Thromb Res"},{"key":"1524_CR34","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1517\/14728222.11.12.1523","volume":"11","author":"TA Duhamel","year":"2007","unstructured":"Duhamel TA, Xu YJ, Arneja AS, Dhalla NS (2007) Targeting platelets for prevention and treatment of cardiovascular disease. Expert Opin Ther Targets 11:1523\u20131533","journal-title":"Expert Opin Ther Targets"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1524-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T18:05:09Z","timestamp":1602439509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1524-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1524-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}